换一批Clinical option of pemetrexed-based versus paclitaxel-based first-line chemotherapeutic regimens in combination with bevacizumab for advanced non-squamous non-small-cell lung cancer and optimal maintenance therapy: evidence from a meta-analysis of randomized control trials.
第一作者：
Le-Tian,Huang
第一单位：
Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, 110022, China.
作者：
主题词
抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);女(雌)性(Female);人类(Humans);肺肿瘤(Lung Neoplasms);男(雄)性(Male);肿瘤转移(Neoplasm Metastasis);肿瘤分期(Neoplasm Staging);紫杉酚(Paclitaxel);出版倾向性(Publication Bias);随机对照试验(主题)(Randomized Controlled Trials as Topic);治疗结果(Treatment Outcome)
DOI
10.1186/s12885-021-08136-5
PMID
33865364
发布时间
2023-11-11
- 浏览0
BMC cancer
426页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
